Business

A handful of transformative transactions lifted 2025 merger and acquisitions totals, but dealmakers largely remained disciplined, prioritizing data-driven growth and digital platforms.

The company will use the funds to accelerate commercialization of its brain-signal AI technology and expand its cognitive health applications.

In the best case scenario, hospitals “are getting 20% less than the lowest workman’s comp fee schedule in the country,” says Zachary Schultz of EnableComp.

Also, University of Queensland research has found ultrasound to be a safe approach to possibly treat symptoms of Alzheimer's disease in a world's first in-human trial.

Doug Meil, author of The Rise and Fall of Explorys and IBM Watson Health: A Personal Memoir of a Healthcare Moonshot that Misfired, discusses some lessons learned from that era, and offers perspective on where artificial intelligence may be headed next.

Atropos Health CEO, Brigham Hyde, discusses the integration of Atropos' agentic AI agent into Microsoft Teams, helping clinical teams analyze patient information and clinical documentation during team meetings to support decision making.

Ash will provide at-home biomarker testing to Noom users to provide insights into key health markers linked to chronic disease risk and aging.

The department is proposing to reorganize the Veterans Health Administration health agency over the next 18-24 months. Meanwhile, new proposed House bills seek VA reforms.

The federal grants will support CranioSense’s development and validation of its non-invasive intracranial pressure monitoring device.

The company also raised $5 million in venture debt funding.